Bone morphogenetic protein 2 induces pulmonary angiogenesis via Wnt-beta-catenin and Wnt-RhoA-Rac1 pathways.
about
Integration of a Notch-dependent mesenchymal gene program and Bmp2-driven cell invasiveness regulates murine cardiac valve formation.Molecular pathogenesis of pulmonary arterial hypertensionBMPR2 spruces up the endothelium in pulmonary hypertensionTargeting the Wnt signaling pathways in pulmonary arterial hypertensionPulmonary vascular disease related to hemodynamic stress in the pulmonary circulation.Novel signaling pathways in pulmonary arterial hypertension (2015 Grover Conference Series)Non-canonical WNT signalling in the lungWhole-exome sequencing reveals TopBP1 as a novel gene in idiopathic pulmonary arterial hypertensionUniaxial mechanical tension promoted osteogenic differentiation of rat tendon-derived stem cells (rTDSCs) via the Wnt5a-RhoA pathwayPI3K and ERK-induced Rac1 activation mediates hypoxia-induced HIF-1α expression in MCF-7 breast cancer cells.Secreted frizzled-related protein 4: an angiogenesis inhibitor.Chronic lung disease in the preterm infant. Lessons learned from animal modelsInflammation and the osteogenic regulation of vascular calcification: a review and perspective.Interaction between bone morphogenetic protein receptor type 2 and estrogenic compounds in pulmonary arterial hypertensionGlycogen synthase kinase 3beta contributes to proliferation of arterial smooth muscle cells in pulmonary hypertension.PDGF-CC blockade inhibits pathological angiogenesis by acting on multiple cellular and molecular targets.The cross-talk between canonical and non-canonical Wnt-dependent pathways regulates P-glycoprotein expression in human blood-brain barrier cells.Identification of a common Wnt-associated genetic signature across multiple cell types in pulmonary arterial hypertension.WSS25 inhibits growth of xenografted hepatocellular cancer cells in nude mice by disrupting angiogenesis via blocking bone morphogenetic protein (BMP)/Smad/Id1 signalingExpression of canonical WNT/β-CATENIN signaling components in the developing human lung.BMP promotes motility and represses growth of smooth muscle cells by activation of tandem Wnt pathwaysActivation of the Wnt/planar cell polarity pathway is required for pericyte recruitment during pulmonary angiogenesis.Reversal of ischemic cardiomyopathy with Sca-1+ stem cells modified with multiple growth factorsDisruption of PPARγ/β-catenin-mediated regulation of apelin impairs BMP-induced mouse and human pulmonary arterial EC survivalBone morphogenetic protein receptor II is a novel mediator of endothelial nitric-oxide synthase activation.Rescuing the BMPR2 signaling axis in pulmonary arterial hypertensionElafin Reverses Pulmonary Hypertension via Caveolin-1-Dependent Bone Morphogenetic Protein Signaling.Cytoskeletal defects in Bmpr2-associated pulmonary arterial hypertensionA critical role for endoglin in the emergence of blood during embryonic development.RNA Sequencing Analysis Detection of a Novel Pathway of Endothelial Dysfunction in Pulmonary Arterial Hypertension.Raf/ERK drives the proliferative and invasive phenotype of BMPR2-silenced pulmonary artery endothelial cells.In vivo knockdown of intersectin-1s alters endothelial cell phenotype and causes microvascular remodeling in the mouse lungsGene expression analysis of a murine model with pulmonary vascular remodeling compared to end-stage IPAH lungsActivated amelogenin Y-linked (AMELY) regulation and angiogenesis in human hepatocellular carcinoma by biocomputation.Mechanics and mechanisms of pulmonary hypertension-Conference summary and translational perspectives.In Pulmonary Arterial Hypertension, Reduced BMPR2 Promotes Endothelial-to-Mesenchymal Transition via HMGA1 and Its Target SlugVascular tissues are a primary source of BMP2 expression during bone formation induced by distraction osteogenesisFK506 activates BMPR2, rescues endothelial dysfunction, and reverses pulmonary hypertension.Gender, sex hormones and pulmonary hypertension.Mutant LRP6 Impairs Endothelial Cell Functions Associated with Familial Normolipidemic Coronary Artery Disease
P2860
Q24301606-BB41334F-A02B-4AEB-9F85-54C039444E8FQ24634317-8DDCCF6D-EAF0-413E-95E3-04A091FC7C30Q26786834-AA3175F6-26E1-470F-BA15-323BB4BBBC87Q27006826-38E2FFF2-8927-4CA9-8A0F-4B5DC935985AQ27687091-9F8B65F9-FE8B-4EB9-A4C2-78E7F621FAF1Q28078976-663E517B-91AF-4D4B-B057-ACD79BBD1DBBQ28080483-DC0A2FF8-BE70-4879-858D-4F70CB8D8DB0Q28237461-0B4DE696-A10C-40A5-AB12-29118A37C456Q28572810-895E1305-C918-4A00-B405-B46FF46F04A7Q30430373-D7925A01-9D20-45F3-86DE-85F86DA3198EQ33703825-040969E2-C794-4A4B-A71F-B39AA320FE56Q33756577-9E5907A0-B41F-4505-A71D-A6D33606ABE1Q33782750-D0A81C42-24CC-4687-851E-BBE4F20841AEQ33806083-0AF81877-BFE4-44E2-A127-9017A43B1427Q33886299-C0E063BD-73BE-49E4-980F-24486C83679CQ33981871-A4B62F7D-59E3-477B-940E-0E436370A671Q34018635-A0BA8B7C-DF02-4777-BBB6-1F6B3AF1D170Q34130859-BD9DC7F9-9FC3-4500-9AB6-F7863A41CE79Q34186700-5A326705-21EE-468B-B304-D9894524091EQ34356715-01D68541-6742-4809-BC61-F45EDF0A0A22Q34483074-CBFE484E-0A41-48F7-A99B-35842B9251D5Q34780828-4A41C41E-BE95-4A94-AA63-636D4D2C931CQ35140094-AD61DD40-B5F6-4F0B-9188-5A6EED7D79D4Q35187029-E2C2A9D1-327E-4275-BFEB-E496528AE995Q35311990-AAA391AE-3165-4910-B863-9F118E1C2723Q35410950-6A599285-D004-4223-B7F7-4FA6439ADA3BQ35766693-FFCDECB1-F970-4A37-AC5B-903D64999074Q35850232-2260F8D5-AAEF-4438-82E0-AB513124D1A4Q36015189-8A757196-DF38-4EF1-AB42-C2FFDF71F7FEQ36096312-6ECA9663-70AA-4DC6-A2E2-7C2E87775B7BQ36480359-A100C81B-79A9-4E20-9244-DBD5424E746AQ36527847-AAD9ADA6-F954-4E15-B635-1957E6AF38A9Q36535637-6AB515AA-3C47-4C32-93C6-A14C49D24CB7Q36621353-394FF432-9FC6-4E1F-B156-A7364787B1E3Q36810785-21E5EEB1-1874-4690-9B2C-CE89A7AD71DBQ36869381-B5C3CCB9-A8B0-459E-8BE7-3F52B21AD8ABQ37037233-14342EFD-F817-4867-8689-3517D49492D0Q37052894-5BFF57B9-42FE-4402-AD81-E6A4C168D7AEQ37133789-531B3EE2-7FC9-4285-8D90-B485E85CC8F5Q37134712-EF611FA0-908C-46CA-9000-10CCBFAA4D56
P2860
Bone morphogenetic protein 2 induces pulmonary angiogenesis via Wnt-beta-catenin and Wnt-RhoA-Rac1 pathways.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Bone morphogenetic protein 2 i ...... in and Wnt-RhoA-Rac1 pathways.
@ast
Bone morphogenetic protein 2 i ...... in and Wnt-RhoA-Rac1 pathways.
@en
type
label
Bone morphogenetic protein 2 i ...... in and Wnt-RhoA-Rac1 pathways.
@ast
Bone morphogenetic protein 2 i ...... in and Wnt-RhoA-Rac1 pathways.
@en
prefLabel
Bone morphogenetic protein 2 i ...... in and Wnt-RhoA-Rac1 pathways.
@ast
Bone morphogenetic protein 2 i ...... in and Wnt-RhoA-Rac1 pathways.
@en
P2093
P2860
P50
P356
P1476
Bone morphogenetic protein 2 i ...... nin and Wnt-RhoA-Rac1 pathways
@en
P2093
Jenny C Wu
Marlene Rabinovitch
Tero-Pekka Alastalo
Vinicio A de Jesus Perez
P2860
P356
10.1083/JCB.200806049
P407
P577
2009-01-01T00:00:00Z